| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
NF-kappa B | 34 | 1995 | 114 |
Why?
|
HIV-1 | 17 | 1995 | 93 |
Why?
|
Gene Products, tat | 9 | 1998 | 13 |
Why?
|
Neurons | 18 | 1998 | 195 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 11 | 1998 | 15 |
Why?
|
Glycogen Synthase Kinase 3 | 9 | 1999 | 26 |
Why?
|
Signal Transduction | 19 | 1995 | 313 |
Why?
|
AIDS Dementia Complex | 12 | 1999 | 24 |
Why?
|
Nerve Growth Factors | 4 | 1998 | 43 |
Why?
|
MAP Kinase Kinase Kinases | 4 | 2006 | 28 |
Why?
|
Blood Platelets | 4 | 2009 | 67 |
Why?
|
Microglia | 5 | 1999 | 29 |
Why?
|
Cell Survival | 13 | 1995 | 229 |
Why?
|
Valproic Acid | 4 | 2003 | 26 |
Why?
|
Apoptosis | 14 | 1996 | 265 |
Why?
|
CD40 Ligand | 3 | 2007 | 51 |
Why?
|
Transcription Factor RelB | 6 | 1996 | 15 |
Why?
|
Cells, Cultured | 24 | 1994 | 447 |
Why?
|
Monocytes | 5 | 2003 | 124 |
Why?
|
Tumor Necrosis Factor-alpha | 10 | 1995 | 210 |
Why?
|
Cerebellum | 6 | 1999 | 59 |
Why?
|
Animals | 44 | 1994 | 1031 |
Why?
|
Nerve Growth Factor | 3 | 2000 | 20 |
Why?
|
Adenosine | 4 | 1994 | 57 |
Why?
|
Rats | 20 | 1994 | 530 |
Why?
|
Platelet Activation | 2 | 2010 | 18 |
Why?
|
I-kappa B Proteins | 6 | 1995 | 33 |
Why?
|
HIV Infections | 5 | 2005 | 136 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2000 | 28 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 1999 | 48 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2011 | 18 |
Why?
|
Lithium | 3 | 2005 | 28 |
Why?
|
Rats, Sprague-Dawley | 11 | 1999 | 257 |
Why?
|
Pyridines | 1 | 2011 | 61 |
Why?
|
Lung | 5 | 2007 | 232 |
Why?
|
DNA-Binding Proteins | 9 | 1995 | 204 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2010 | 19 |
Why?
|
Down-Regulation | 2 | 2008 | 150 |
Why?
|
Macrophages | 10 | 1999 | 148 |
Why?
|
Enzyme Activation | 10 | 1999 | 177 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2009 | 11 |
Why?
|
Receptor, Adenosine A2A | 2 | 2004 | 6 |
Why?
|
Transcription Factor RelA | 9 | 1995 | 36 |
Why?
|
Immunoblotting | 5 | 2003 | 119 |
Why?
|
Orthomyxoviridae Infections | 1 | 2010 | 29 |
Why?
|
Nuclear Proteins | 5 | 1996 | 139 |
Why?
|
Ankyrin Repeat | 1 | 2008 | 2 |
Why?
|
Influenza A virus | 1 | 2010 | 63 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2009 | 41 |
Why?
|
Mice | 18 | 1996 | 623 |
Why?
|
Membrane Microdomains | 1 | 2006 | 6 |
Why?
|
Humans | 44 | 1994 | 1856 |
Why?
|
Inflammation Mediators | 3 | 2010 | 56 |
Why?
|
Protein Kinase Inhibitors | 6 | 2006 | 59 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 5 | 2006 | 48 |
Why?
|
Inflammation | 5 | 2007 | 208 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 128 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2003 | 68 |
Why?
|
Ganglia, Sympathetic | 1 | 2004 | 11 |
Why?
|
Enzyme Inhibitors | 6 | 1995 | 216 |
Why?
|
Carbazoles | 3 | 2006 | 21 |
Why?
|
Antioxidants | 3 | 1994 | 84 |
Why?
|
Neuroprotective Agents | 5 | 2001 | 60 |
Why?
|
Cell Line | 10 | 1994 | 375 |
Why?
|
Membrane Proteins | 1 | 2008 | 233 |
Why?
|
Antigens, CD28 | 3 | 1996 | 25 |
Why?
|
Mice, Inbred C57BL | 8 | 2005 | 318 |
Why?
|
Gene Products, tax | 3 | 1995 | 4 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 38 |
Why?
|
Cell Line, Tumor | 9 | 2005 | 208 |
Why?
|
Transcription Factors | 5 | 1996 | 201 |
Why?
|
Phosphorylation | 8 | 1995 | 224 |
Why?
|
Adenosine Deaminase | 2 | 1994 | 8 |
Why?
|
Astrocytes | 1 | 2003 | 62 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2006 | 51 |
Why?
|
Smoking | 3 | 2006 | 153 |
Why?
|
Cysteine Endopeptidases | 3 | 1995 | 41 |
Why?
|
PPAR gamma | 3 | 2006 | 38 |
Why?
|
Multienzyme Complexes | 3 | 1995 | 45 |
Why?
|
In Situ Nick-End Labeling | 3 | 2001 | 65 |
Why?
|
Electrophoretic Mobility Shift Assay | 3 | 2004 | 45 |
Why?
|
Trans-Activators | 2 | 1999 | 113 |
Why?
|
Adrenergic Fibers | 1 | 1998 | 13 |
Why?
|
Lentivirus | 2 | 2006 | 20 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2008 | 16 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 2 | 2008 | 21 |
Why?
|
Phosphoprotein Phosphatases | 3 | 1995 | 21 |
Why?
|
Interleukin-2 | 2 | 1996 | 71 |
Why?
|
I-kappa B Kinase | 4 | 2003 | 26 |
Why?
|
Gene Therapy | 2 | 2011 | 89 |
Why?
|
Phenylisopropyladenosine | 2 | 1994 | 4 |
Why?
|
Immunoprecipitation | 2 | 2006 | 57 |
Why?
|
Epithelial Cells | 4 | 2005 | 135 |
Why?
|
Genetic Vectors | 3 | 2006 | 139 |
Why?
|
Culture Media, Conditioned | 2 | 2006 | 45 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 1996 | 71 |
Why?
|
Cysteine Proteinase Inhibitors | 5 | 1995 | 19 |
Why?
|
Transfection | 8 | 1996 | 237 |
Why?
|
PC12 Cells | 4 | 2000 | 27 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 1997 | 5 |
Why?
|
Fibroblasts | 3 | 2008 | 179 |
Why?
|
Human T-lymphotropic virus 1 | 4 | 1995 | 8 |
Why?
|
Cognition Disorders | 2 | 2009 | 107 |
Why?
|
Transcription, Genetic | 3 | 2000 | 253 |
Why?
|
Cyclooxygenase 2 | 3 | 2003 | 77 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2006 | 38 |
Why?
|
Adenosine A1 Receptor Agonists | 2 | 2004 | 5 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2004 | 243 |
Why?
|
T-Lymphocytes | 5 | 1995 | 182 |
Why?
|
Peptide Hydrolases | 2 | 1998 | 38 |
Why?
|
Indoles | 2 | 2006 | 69 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1997 | 77 |
Why?
|
Catalase | 2 | 1994 | 27 |
Why?
|
Glutathione Peroxidase | 2 | 1994 | 24 |
Why?
|
Receptors, Aryl Hydrocarbon | 2 | 2007 | 23 |
Why?
|
RNA, Messenger | 4 | 2003 | 394 |
Why?
|
Histone Deacetylases | 2 | 2006 | 30 |
Why?
|
Superoxide Dismutase | 2 | 1994 | 46 |
Why?
|
Lipopolysaccharides | 3 | 1999 | 98 |
Why?
|
Gene Expression Regulation | 4 | 1996 | 277 |
Why?
|
Potassium | 2 | 2004 | 98 |
Why?
|
Precipitin Tests | 2 | 2003 | 81 |
Why?
|
Blotting, Western | 7 | 1997 | 275 |
Why?
|
Pulmonary Alveoli | 2 | 2005 | 80 |
Why?
|
Cell Death | 4 | 2001 | 94 |
Why?
|
Mice, Transgenic | 3 | 2008 | 209 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2006 | 58 |
Why?
|
Mitochondria | 2 | 2004 | 100 |
Why?
|
Megakaryocytes | 2 | 2009 | 19 |
Why?
|
Viral Load | 2 | 2009 | 53 |
Why?
|
Animals, Newborn | 2 | 2004 | 175 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2001 | 431 |
Why?
|
Pilot Projects | 2 | 2009 | 264 |
Why?
|
Mice, Knockout | 3 | 2007 | 265 |
Why?
|
Lectins, C-Type | 1 | 2011 | 19 |
Why?
|
Serine | 2 | 1996 | 62 |
Why?
|
Communicable Diseases | 1 | 2011 | 22 |
Why?
|
Genes, Reporter | 3 | 1997 | 111 |
Why?
|
Cerebral Cortex | 3 | 2006 | 108 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2010 | 6 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2010 | 17 |
Why?
|
Glutamic Acid | 1 | 2011 | 66 |
Why?
|
Hair Cells, Auditory | 1 | 2010 | 12 |
Why?
|
Solubility | 1 | 2010 | 75 |
Why?
|
Cell Membrane | 2 | 2009 | 170 |
Why?
|
Hearing Loss | 1 | 2010 | 17 |
Why?
|
Calpain | 1 | 2010 | 15 |
Why?
|
Platelet Activating Factor | 2 | 1999 | 18 |
Why?
|
Antigens, CD40 | 1 | 2010 | 24 |
Why?
|
NF-kappa B p50 Subunit | 4 | 1996 | 23 |
Why?
|
Indole Alkaloids | 1 | 2009 | 5 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2011 | 67 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2003 | 39 |
Why?
|
Tyrphostins | 1 | 2009 | 14 |
Why?
|
RNA, Neoplasm | 1 | 2009 | 41 |
Why?
|
Autocrine Communication | 1 | 2009 | 24 |
Why?
|
Sulfhydryl Compounds | 1 | 2009 | 42 |
Why?
|
Sesquiterpenes | 1 | 2009 | 24 |
Why?
|
Blood-Brain Barrier | 1 | 2010 | 63 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2003 | 67 |
Why?
|
Promoter Regions, Genetic | 4 | 1996 | 188 |
Why?
|
Lithium Compounds | 1 | 2009 | 10 |
Why?
|
Cell Differentiation | 3 | 2003 | 262 |
Why?
|
B-Cell-Specific Activator Protein | 1 | 2008 | 4 |
Why?
|
Protein Binding | 3 | 1996 | 256 |
Why?
|
Proto-Oncogene Proteins | 4 | 1996 | 113 |
Why?
|
HIV Envelope Protein gp120 | 2 | 2003 | 15 |
Why?
|
Pneumonia | 1 | 2011 | 85 |
Why?
|
Interleukin-8 | 2 | 2006 | 54 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2008 | 18 |
Why?
|
Transduction, Genetic | 2 | 2006 | 65 |
Why?
|
Protein Folding | 1 | 2008 | 30 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 224 |
Why?
|
Leupeptins | 3 | 1995 | 14 |
Why?
|
Immunoglobulin G | 1 | 2011 | 191 |
Why?
|
Fluorescent Antibody Technique | 2 | 2004 | 164 |
Why?
|
Burkitt Lymphoma | 1 | 2008 | 36 |
Why?
|
Cell Division | 2 | 1999 | 273 |
Why?
|
Prostaglandins | 1 | 2008 | 41 |
Why?
|
DNA Replication | 1 | 2009 | 75 |
Why?
|
Adenoviridae | 2 | 2003 | 60 |
Why?
|
Chemokines | 2 | 2005 | 48 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 99 |
Why?
|
Anti-HIV Agents | 2 | 2006 | 44 |
Why?
|
Male | 10 | 2003 | 1553 |
Why?
|
tau Proteins | 2 | 2003 | 15 |
Why?
|
Brain | 3 | 2005 | 305 |
Why?
|
Ion Channel Gating | 1 | 2008 | 42 |
Why?
|
Cell Communication | 1 | 2008 | 72 |
Why?
|
Drug Interactions | 2 | 2003 | 111 |
Why?
|
Antibodies, Viral | 1 | 2010 | 104 |
Why?
|
Intracranial Hemorrhages | 1 | 2006 | 11 |
Why?
|
Pneumocystis Infections | 1 | 2007 | 12 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2007 | 54 |
Why?
|
Chromatin | 1 | 2008 | 29 |
Why?
|
Green Fluorescent Proteins | 2 | 2004 | 105 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2007 | 32 |
Why?
|
Phenethylamines | 2 | 1997 | 17 |
Why?
|
Tissue Plasminogen Activator | 1 | 2006 | 31 |
Why?
|
Disease Models, Animal | 5 | 2003 | 349 |
Why?
|
Oleanolic Acid | 1 | 2006 | 13 |
Why?
|
Repressor Proteins | 1 | 2008 | 96 |
Why?
|
Culture Media, Serum-Free | 1 | 2006 | 32 |
Why?
|
Protein C | 1 | 2006 | 28 |
Why?
|
Antigens, Neoplasm | 1 | 2007 | 56 |
Why?
|
Defective Viruses | 1 | 2006 | 13 |
Why?
|
Respiratory Mucosa | 1 | 2007 | 39 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 55 |
Why?
|
HIV-2 | 1 | 2005 | 4 |
Why?
|
Chemokine CCL2 | 1 | 2007 | 57 |
Why?
|
Receptors, Purinergic P1 | 2 | 1994 | 19 |
Why?
|
DNA | 2 | 1998 | 262 |
Why?
|
Microscopy, Fluorescence | 2 | 2001 | 137 |
Why?
|
Encephalitis, Viral | 1 | 2005 | 11 |
Why?
|
Jurkat Cells | 4 | 1996 | 26 |
Why?
|
Female | 8 | 2005 | 1643 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 33 |
Why?
|
Time Factors | 3 | 1994 | 896 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2006 | 64 |
Why?
|
B-Lymphocytes | 1 | 2009 | 134 |
Why?
|
Mice, SCID | 4 | 2003 | 61 |
Why?
|
Adenosine A2 Receptor Antagonists | 1 | 2004 | 5 |
Why?
|
Receptor, Adenosine A1 | 1 | 2004 | 8 |
Why?
|
Pneumocystis carinii | 1 | 2005 | 18 |
Why?
|
Tumor Cells, Cultured | 6 | 1994 | 233 |
Why?
|
Serum | 1 | 2004 | 7 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2006 | 85 |
Why?
|
Proteome | 1 | 2004 | 25 |
Why?
|
Protein-Serine-Threonine Kinases | 2 | 2003 | 105 |
Why?
|
Luminescent Proteins | 1 | 2004 | 67 |
Why?
|
Caspases | 1 | 2004 | 58 |
Why?
|
Kinetics | 4 | 1994 | 349 |
Why?
|
Mannitol | 1 | 2003 | 29 |
Why?
|
Cell Proliferation | 4 | 2006 | 227 |
Why?
|
Glycogen Synthase Kinases | 2 | 1999 | 7 |
Why?
|
Recombinant Proteins | 3 | 1996 | 290 |
Why?
|
NFATC Transcription Factors | 3 | 1996 | 15 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 104 |
Why?
|
Luciferases | 1 | 2003 | 70 |
Why?
|
Proto-Oncogene Proteins c-rel | 2 | 1998 | 3 |
Why?
|
DNA, Complementary | 1 | 2003 | 139 |
Why?
|
Glutathione Transferase | 1 | 2003 | 45 |
Why?
|
Nitric Oxide Synthase | 1 | 2003 | 44 |
Why?
|
Cell Fractionation | 1 | 2001 | 42 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 1995 | 61 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 66 |
Why?
|
Protein Structure, Tertiary | 1 | 2003 | 163 |
Why?
|
Gene Expression | 4 | 1999 | 291 |
Why?
|
E1A-Associated p300 Protein | 1 | 2000 | 6 |
Why?
|
Isoenzymes | 1 | 2003 | 144 |
Why?
|
Cell Nucleus | 2 | 1996 | 169 |
Why?
|
Lithium Chloride | 1 | 1999 | 10 |
Why?
|
Antimanic Agents | 1 | 1999 | 7 |
Why?
|
Oxazoles | 2 | 1995 | 8 |
Why?
|
Azepines | 1 | 1999 | 10 |
Why?
|
N-Methylaspartate | 1 | 1999 | 18 |
Why?
|
Neoplasms | 1 | 2007 | 239 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 1999 | 27 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 189 |
Why?
|
Neurotoxins | 1 | 1999 | 33 |
Why?
|
Milk Proteins | 1 | 1999 | 12 |
Why?
|
Octamer Transcription Factor-1 | 1 | 1998 | 4 |
Why?
|
Host Cell Factor C1 | 1 | 1998 | 4 |
Why?
|
Triazoles | 1 | 1999 | 31 |
Why?
|
Superior Cervical Ganglion | 1 | 1998 | 5 |
Why?
|
Cell Adhesion | 2 | 2009 | 113 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2003 | 59 |
Why?
|
Ligands | 2 | 2008 | 116 |
Why?
|
Hydrolysis | 1 | 1998 | 57 |
Why?
|
Transcription Factor AP-1 | 1 | 1998 | 42 |
Why?
|
Glutathione Reductase | 2 | 1994 | 13 |
Why?
|
Oligopeptides | 1 | 1998 | 56 |
Why?
|
Dimerization | 1 | 1998 | 92 |
Why?
|
Embryo, Mammalian | 1 | 1998 | 99 |
Why?
|
PTEN Phosphohydrolase | 2 | 2006 | 14 |
Why?
|
Oncogene Proteins v-rel | 1 | 1997 | 2 |
Why?
|
Phytohemagglutinins | 1 | 1997 | 25 |
Why?
|
Flow Cytometry | 2 | 2009 | 216 |
Why?
|
RNA Interference | 2 | 2007 | 75 |
Why?
|
Antigens, CD3 | 1 | 1997 | 37 |
Why?
|
Cochlea | 1 | 1997 | 14 |
Why?
|
Antigens, CD95 | 1 | 1996 | 16 |
Why?
|
Mutation | 1 | 2003 | 340 |
Why?
|
Oncogenes | 1 | 1996 | 24 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 1996 | 21 |
Why?
|
Peptides | 1 | 1998 | 154 |
Why?
|
Basal Ganglia | 2 | 2003 | 23 |
Why?
|
Chemokine CXCL2 | 2 | 2005 | 29 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2007 | 68 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 1996 | 167 |
Why?
|
Glutathione | 2 | 2006 | 65 |
Why?
|
Molecular Sequence Data | 3 | 1995 | 404 |
Why?
|
Protein Precursors | 1 | 1996 | 48 |
Why?
|
Amino Acid Sequence | 2 | 1995 | 319 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 2 | 1997 | 21 |
Why?
|
Interleukin-6 | 2 | 2007 | 145 |
Why?
|
Leukemia, Basophilic, Acute | 1 | 1994 | 4 |
Why?
|
Mast-Cell Sarcoma | 1 | 1994 | 9 |
Why?
|
Virus Replication | 2 | 2006 | 90 |
Why?
|
Theophylline | 1 | 1994 | 19 |
Why?
|
Lymphocyte Activation | 1 | 1996 | 137 |
Why?
|
Pertussis Toxin | 1 | 1994 | 25 |
Why?
|
Virulence Factors, Bordetella | 1 | 1994 | 22 |
Why?
|
Coculture Techniques | 2 | 2003 | 59 |
Why?
|
Enzyme Induction | 1 | 1994 | 64 |
Why?
|
Cell Movement | 2 | 2001 | 163 |
Why?
|
DNA Probes | 3 | 1996 | 61 |
Why?
|
Oxidative Stress | 3 | 1997 | 119 |
Why?
|
Myocardium | 1 | 1994 | 119 |
Why?
|
Models, Biological | 2 | 2006 | 410 |
Why?
|
Middle Aged | 3 | 2009 | 1161 |
Why?
|
Administration, Intranasal | 1 | 2011 | 25 |
Why?
|
Bronchoalveolar Lavage | 1 | 2011 | 24 |
Why?
|
Fetus | 2 | 1999 | 105 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2011 | 6 |
Why?
|
Treatment Outcome | 2 | 2009 | 661 |
Why?
|
Otoacoustic Emissions, Spontaneous | 1 | 2010 | 12 |
Why?
|
Fibrosis | 1 | 2011 | 46 |
Why?
|
Gentamicins | 1 | 2010 | 32 |
Why?
|
Adult | 3 | 2009 | 1317 |
Why?
|
Mesencephalon | 1 | 2010 | 22 |
Why?
|
Protease Inhibitors | 1 | 2010 | 39 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 125 |
Why?
|
Subcellular Fractions | 1 | 2010 | 67 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 27 |
Why?
|
Protein Processing, Post-Translational | 2 | 1995 | 78 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 2009 | 10 |
Why?
|
Hemostasis | 1 | 2010 | 44 |
Why?
|
Gliosis | 1 | 2009 | 14 |
Why?
|
Cell Shape | 1 | 2009 | 20 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2009 | 27 |
Why?
|
Nitriles | 1 | 2009 | 27 |
Why?
|
Sulfones | 1 | 2009 | 23 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2011 | 51 |
Why?
|
Thioredoxins | 1 | 2009 | 16 |
Why?
|
Endothelium, Vascular | 1 | 1994 | 139 |
Why?
|
Extracellular Space | 1 | 2009 | 58 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 62 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2009 | 55 |
Why?
|
Fetal Blood | 1 | 2009 | 54 |
Why?
|
Dinoprostone | 1 | 2011 | 55 |
Why?
|
Neutrophils | 1 | 2011 | 114 |
Why?
|
Mitochondrial Membranes | 1 | 2008 | 12 |
Why?
|
Gene Knockdown Techniques | 1 | 2008 | 26 |
Why?
|
CD4 Lymphocyte Count | 1 | 2009 | 50 |
Why?
|
Phosphorylcholine | 1 | 2008 | 11 |
Why?
|
Antidepressive Agents | 1 | 2009 | 46 |
Why?
|
Lymphoma | 1 | 2009 | 96 |
Why?
|
Tobacco | 1 | 2008 | 24 |
Why?
|
Endoplasmic Reticulum | 1 | 2008 | 59 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2008 | 53 |
Why?
|
Protein Transport | 1 | 2008 | 101 |
Why?
|
Epigenesis, Genetic | 1 | 2008 | 11 |
Why?
|
Analysis of Variance | 1 | 2010 | 339 |
Why?
|
Smoke | 1 | 2008 | 20 |
Why?
|
beta 2-Microglobulin | 1 | 2007 | 17 |
Why?
|
Culture Media | 1 | 2008 | 116 |
Why?
|
beta-Glucans | 1 | 2007 | 10 |
Why?
|
Enhancer Elements, Genetic | 2 | 1996 | 43 |
Why?
|
Endothelial Cells | 1 | 2010 | 80 |
Why?
|
Macrophages, Alveolar | 1 | 2008 | 44 |
Why?
|
Up-Regulation | 1 | 2008 | 183 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2006 | 42 |
Why?
|
Killer Cells, Natural | 1 | 2007 | 62 |
Why?
|
Thioredoxin-Disulfide Reductase | 1 | 2006 | 5 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 2006 | 10 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2007 | 52 |
Why?
|
MAP Kinase Signaling System | 1 | 2007 | 56 |
Why?
|
Xenopus laevis | 1 | 2007 | 49 |
Why?
|
Immunization | 1 | 2007 | 85 |
Why?
|
Histones | 1 | 2008 | 42 |
Why?
|
Cytokines | 1 | 2009 | 207 |
Why?
|
HeLa Cells | 2 | 1996 | 107 |
Why?
|
Transcriptional Activation | 2 | 1996 | 99 |
Why?
|
Abortion, Induced | 1 | 2005 | 26 |
Why?
|
Oxidants | 1 | 2006 | 47 |
Why?
|
Feasibility Studies | 1 | 2006 | 144 |
Why?
|
Models, Genetic | 1 | 2006 | 90 |
Why?
|
Binding Sites | 2 | 1996 | 213 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2006 | 25 |
Why?
|
HIV Core Protein p24 | 1 | 2003 | 17 |
Why?
|
Diuretics, Osmotic | 1 | 2003 | 4 |
Why?
|
Immunohistochemistry | 1 | 2007 | 355 |
Why?
|
Swine | 1 | 2003 | 95 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 294 |
Why?
|
Base Sequence | 2 | 1996 | 371 |
Why?
|
Neuroglia | 1 | 2003 | 49 |
Why?
|
Cricetinae | 1 | 2003 | 130 |
Why?
|
Calcium | 1 | 2008 | 208 |
Why?
|
RNA, Viral | 1 | 2003 | 91 |
Why?
|
Cell Aggregation | 1 | 2001 | 25 |
Why?
|
Biological Markers | 1 | 2003 | 262 |
Why?
|
Nitric Oxide | 1 | 2003 | 85 |
Why?
|
STAT5 Transcription Factor | 1 | 1999 | 8 |
Why?
|
Cell Line, Transformed | 1 | 1999 | 52 |
Why?
|
Cell Transformation, Viral | 1 | 1999 | 35 |
Why?
|
STAT3 Transcription Factor | 1 | 1999 | 19 |
Why?
|
Receptors, IgG | 1 | 1999 | 30 |
Why?
|
Phagocytosis | 1 | 1999 | 51 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1998 | 38 |
Why?
|
Cochlear Microphonic Potentials | 1 | 1997 | 2 |
Why?
|
Purinergic P1 Receptor Agonists | 1 | 1997 | 2 |
Why?
|
Round Window, Ear | 1 | 1997 | 2 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 1997 | 4 |
Why?
|
Xanthines | 1 | 1997 | 10 |
Why?
|
Chinchilla | 1 | 1997 | 7 |
Why?
|
Malondialdehyde | 1 | 1997 | 8 |
Why?
|
Radioligand Assay | 1 | 1997 | 30 |
Why?
|
Lamins | 1 | 1996 | 3 |
Why?
|
Lamin Type B | 1 | 1996 | 3 |
Why?
|
Aged | 1 | 2009 | 988 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 1997 | 12 |
Why?
|
Lipid Peroxidation | 1 | 1997 | 23 |
Why?
|
DNA Fragmentation | 1 | 1996 | 35 |
Why?
|
Activating Transcription Factors | 1 | 1996 | 2 |
Why?
|
Binding, Competitive | 1 | 1997 | 109 |
Why?
|
Phosphopeptides | 1 | 1996 | 7 |
Why?
|
Cyclosporine | 1 | 1997 | 45 |
Why?
|
Haplorhini | 1 | 1996 | 43 |
Why?
|
Trypsin | 1 | 1996 | 63 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 1996 | 22 |
Why?
|
Blood Proteins | 1 | 1996 | 71 |
Why?
|
Ethers, Cyclic | 1 | 1995 | 9 |
Why?
|
Okadaic Acid | 1 | 1995 | 12 |
Why?
|
Protein Phosphatase 2 | 1 | 1995 | 15 |
Why?
|
Epitopes | 1 | 1996 | 86 |
Why?
|
Drug Synergism | 1 | 1995 | 104 |
Why?
|
